Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
|
3287162 |
1988 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Southern blotting was used to detect rearrangement of the bcl-2 gene in 104 cases of non-Hodgkin's lymphoma subclassified by the Working Formulation, 24 cases of B cell chronic lymphocytic leukemia (B-CLL) and 14 cases of T cell malignancy.
|
2965608 |
1988 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
CTD_human |
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
|
3287162 |
1988 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
|
2509518 |
1989 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Establishment and characterization of a new human B-cell line (ONHL-1) from non-Hodgkin's lymphoma: constant expression of bcl-2 gene during mitogen-induced growth inhibition.
|
2249898 |
1990 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Twenty cases of Japanese non-Hodgkin's lymphoma with B cell markers were studied with respect to their immunoglobulin heavy (IgH) chain gene loci on chromosome 14 and BCL2 loci on chromosome 18.
|
1747446 |
1991 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
Twenty-nine cases of non-Hodgkin's lymphoma of low-grade malignancy in a European population were investigated for the presence of bcl-2 and bcl-1 gene rearrangement.
|
1757070 |
1991 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.
|
8270971 |
1994 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
The cumulative poor effect of both p53 and bcl-2 in large B-cell lymphomas, which is more significant in nodal tumours, could confirm the existence of a multistep genetic deregulation in non-Hodgkin's lymphoma.
|
8297731 |
1994 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
Interestingly these fragile sites were located in the same chromosomal bands as the oncogenes, MOS, MYC, BCL-1 and BCL-2 as well as cancer breakpoints specifically associated with non-Hodgkin's lymphoma, suggesting the possibility that fragile sites may play a critical role in the pathogenesis of non-Hodgkin's lymphoma.
|
7954347 |
1994 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation.
|
7723399 |
1995 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Translocations and amplification of the BCL2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome clones.
|
7632955 |
1995 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
|
8528964 |
1995 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
We conclude that bcl-2 gene deregulation, but not the precise moment at which this occurs during the pre-B-cell stage, influences the development of follicular NHL.
|
8555066 |
1995 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
|
8574164 |
1995 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
|
8704213 |
1996 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
|
8558921 |
1996 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
Furthermore, in another series of 11 patients and a NHL cell line, we demonstrated t(14;18) and t(11;14) in interphase and metaphase cells with a combination of BCL2 (or PRAD1) with IgH gene probes.
|
9209369 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
These results indicate an IGL-mediated rearrangement of an unknown gene at 9q34 that together with BCL2 and MYC might be involved in the lymphomagenesis of the present case of FCCL and perhaps in other cases of non-Hodgkin lymphoma in which t(9;22) is sporadically occurring.
|
9331562 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In order to clarify the effects of Epstein-Barr virus (EBV) infection on apoptosis and proliferative activity of non-Hodgkin's lymphoma, 135 Japanese lymphoma cases were investigated for the presence of viral RNA and its correlation with bcl-2 protein (Bcl-2) expression.
|
9260592 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
Among lymphomas, IgH monoclonality was detected in 7 (77%) of 9 NHLs and BCL2 rearrangement in 3 (17.6%) of 17 NHLs, all of which were follicular centroblastic-centrocytic (FCBCC).
|
9276187 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
NHL is commoner in men than in women, and our data indicate a trend toward higher bcl2 mutagenesis in males than females.
|
9020305 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma.
|
9113013 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
Biomarker
|
disease |
BEFREE |
The first member of this gene family to be identified was BCL-2, by virtue of its involvement in t(14;18) chromosomal translocations commonly found in B-cell non-Hodgkin's lymphoma (NHL).
|
9408956 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Other studies have suggested an inverse relationship between p53 and bcl-2 protein expression in breast and colonic cancers and in a variety of subtypes of non-Hodgkin's lymphoma.
|
9349233 |
1997 |